Rational design of an immunogen for protection against plasmodium vivax malaria

Ended Cooperative Agreement Awarded Last action

Award ID
W81XWH2220033
Recipient
Awarding agency
Obligated
$1,157,298

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Funding
  • $578,649.00 Federal
  • $578,649.00 Non-federal
Place of performance
Tacoma, WA 98402, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The Department of the Army Medical Command awarded a $1,157,298 cooperative agreement to The Geneva Foundation of Tacoma, WA from September 1, 2022 through August 31, 2025. The award will support research under the Military Medical Research and Development program (CFDA 12.420) to rationally design an immunogen for protection against Plasmodium vivax malaria. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research, including investigating medical solutions for battlefield conditions. Under this cooperative agreement, The Geneva Foundation will apply its expertise to develop an immunogen that could help prevent and control P. vivax malaria, a disease which poses health risks both militarily and globally.

Quick answers

Who received award W81XWH2220033?

W81XWH2220033 was awarded to The Geneva Foundation by Medical Command (Department of the Army) on September 1, 2022.

How much is award W81XWH2220033 worth?

$1,157,298 has been obligated on W81XWH2220033: $578,649 in federal funding and $578,649 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login